_id
6919ecd03c536f8df231841c
Ticker
POLX.LSE
Name
Polarean Imaging Plc
Exchange
LSE
Address
27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://polarean.com
Description
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest coil; Polarean 9820 Xenon hyperpolarizer that is designed to deliver up to 3 litres of hyperpolarized 129Xe per hour; and Polarean 2881 polarization measurement station, which provides a calibrated measurement of the polarization of hyperpolarized gas within the dose delivery inhalation bag. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Last Close
1000
Volume
388976
Current Price
0.08
Change
-20.000000000000004
Last Updated
2025-11-26T09:11:35.487Z
Image
https://logo.clearbit.com/polarean.com
Ipo Date
-
Market Cap
905274
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
458789
Cost Of Revenue
389018
Gross Profit
69771
Operating Expenses
4149043
Operating Income
-4079271
Interest Expense
10131
Pretax Income
-3908907
Net Income
-3908907
Eps
-0.003238443115655531
Dividends Per Share
-
Shares Outstanding
1207032781
Income Tax Expense
-
EBITDA
-3722346
Operating Margin
-889.1387980095425
Total Other Income Expense Net
170363
Cash
7277619
Short Term Investments
-
Receivables
348772
Inventories
2251236
Total Current Assets
9877627
Property Plant Equipment
611764
Total Assets
11073494
Payables
2494814
Short Term Debt
-
Long Term Debt
-
Total Liabilities
3182717
Equity
7890777
Depreciation
176431
Change In Working Capital
-546994
Cash From Operations
-3737066
Capital Expenditures
29953
Cash From Investing
-29953
Cash From Financing
-58649
Net Change In Cash
-4360025
PE
-
PB
12.237403551006448
ROE
-49.537669104069224
ROA
-35.29967144967975
FCF
-3767019
Fcf Percent
-8.210787529779484
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
458789
Quarters > 0 > income Statement > cost Of Revenue
389018
Quarters > 0 > income Statement > gross Profit
69771
Quarters > 0 > income Statement > operating Expenses
4149043
Quarters > 0 > income Statement > operating Income
-4079271
Quarters > 0 > income Statement > interest Expense
10131
Quarters > 0 > income Statement > pretax Income
-3908907
Quarters > 0 > income Statement > net Income
-3908907
Quarters > 0 > income Statement > eps
-0.003238443115655531
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1207032781
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3722346
Quarters > 0 > income Statement > operating Margin
-889.1387980095425
Quarters > 0 > income Statement > total Other Income Expense Net
170363
Quarters > 0 > balance Sheet > cash
7277619
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
348772
Quarters > 0 > balance Sheet > inventories
2251236
Quarters > 0 > balance Sheet > total Current Assets
9877627
Quarters > 0 > balance Sheet > property Plant Equipment
611764
Quarters > 0 > balance Sheet > total Assets
11073494
Quarters > 0 > balance Sheet > payables
2494814
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3182717
Quarters > 0 > balance Sheet > equity
7890777
Quarters > 0 > cash Flow > net Income
-3908907
Quarters > 0 > cash Flow > depreciation
176431
Quarters > 0 > cash Flow > change In Working Capital
-546994
Quarters > 0 > cash Flow > cash From Operations
-3737066
Quarters > 0 > cash Flow > capital Expenditures
29953
Quarters > 0 > cash Flow > cash From Investing
-29953
Quarters > 0 > cash Flow > cash From Financing
-58649
Quarters > 0 > cash Flow > net Change In Cash
-4360025
Quarters > 0 > ratios > PE
-0.003238443115655531
Quarters > 0 > ratios > PB
12.237403551006448
Quarters > 0 > ratios > ROE
-49.537669104069224
Quarters > 0 > ratios > ROA
-35.29967144967975
Quarters > 0 > ratios > FCF
-3767019
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-8.210787529779484
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1526195
Quarters > 1 > income Statement > cost Of Revenue
1271252
Quarters > 1 > income Statement > gross Profit
254943
Quarters > 1 > income Statement > operating Expenses
3917978
Quarters > 1 > income Statement > operating Income
-3663034
Quarters > 1 > income Statement > interest Expense
8526.47
Quarters > 1 > income Statement > pretax Income
-3507380
Quarters > 1 > income Statement > net Income
-3507380
Quarters > 1 > income Statement > eps
-0.0029057868644579918
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1207032781
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3102850
Quarters > 1 > income Statement > operating Margin
-240.0108767228303
Quarters > 1 > income Statement > total Other Income Expense Net
155654
Quarters > 1 > balance Sheet > cash
12111708
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
364928
Quarters > 1 > balance Sheet > inventories
1428633
Quarters > 1 > balance Sheet > total Current Assets
14382503
Quarters > 1 > balance Sheet > property Plant Equipment
696020
Quarters > 1 > balance Sheet > total Assets
15792306
Quarters > 1 > balance Sheet > payables
595737
Quarters > 1 > balance Sheet > short Term Debt
129521
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3649701
Quarters > 1 > balance Sheet > equity
12142605
Quarters > 1 > cash Flow > net Income
-3507380
Quarters > 1 > cash Flow > depreciation
396001
Quarters > 1 > cash Flow > change In Working Capital
227607
Quarters > 1 > cash Flow > cash From Operations
-2153157
Quarters > 1 > cash Flow > capital Expenditures
149172
Quarters > 1 > cash Flow > cash From Investing
-149172
Quarters > 1 > cash Flow > cash From Financing
-238680
Quarters > 1 > cash Flow > net Change In Cash
-2366046
Quarters > 1 > ratios > PE
-0.0029057868644579918
Quarters > 1 > ratios > PB
7.952381097795736
Quarters > 1 > ratios > ROE
-28.884905668923594
Quarters > 1 > ratios > ROA
-22.20942274041549
Quarters > 1 > ratios > FCF
-2302329
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.5085418311552588
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
885477
Quarters > 2 > income Statement > cost Of Revenue
783359
Quarters > 2 > income Statement > gross Profit
102117
Quarters > 2 > income Statement > operating Expenses
3281373
Quarters > 2 > income Statement > operating Income
-3179255
Quarters > 2 > income Statement > interest Expense
4089.24
Quarters > 2 > income Statement > pretax Income
-3172581
Quarters > 2 > income Statement > net Income
-3172581
Quarters > 2 > income Statement > eps
-0.011216569232552794
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
282847717
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2809622
Quarters > 2 > income Statement > operating Margin
-359.0443342966559
Quarters > 2 > income Statement > total Other Income Expense Net
6673.87
Quarters > 2 > balance Sheet > cash
15215775
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
529536
Quarters > 2 > balance Sheet > inventories
1977581
Quarters > 2 > balance Sheet > total Current Assets
17722892
Quarters > 2 > balance Sheet > property Plant Equipment
295602
Quarters > 2 > balance Sheet > total Assets
19054035
Quarters > 2 > balance Sheet > payables
2627568
Quarters > 2 > balance Sheet > short Term Debt
147667
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3236545
Quarters > 2 > balance Sheet > equity
15817490
Quarters > 2 > cash Flow > net Income
-3172581
Quarters > 2 > cash Flow > depreciation
358868
Quarters > 2 > cash Flow > change In Working Capital
905455
Quarters > 2 > cash Flow > cash From Operations
-1978362
Quarters > 2 > cash Flow > capital Expenditures
3937.14
Quarters > 2 > cash Flow > cash From Investing
-3936.64
Quarters > 2 > cash Flow > cash From Financing
9163340
Quarters > 2 > cash Flow > net Change In Cash
7195586
Quarters > 2 > ratios > PE
-0.011216569232552794
Quarters > 2 > ratios > PB
1.4305567672241297
Quarters > 2 > ratios > ROE
-20.057423775832955
Quarters > 2 > ratios > ROA
-16.650441756824737
Quarters > 2 > ratios > FCF
-1982299.14
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.238679423632686
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
597401
Quarters > 3 > income Statement > cost Of Revenue
766577
Quarters > 3 > income Statement > gross Profit
-169175
Quarters > 3 > income Statement > operating Expenses
3784050
Quarters > 3 > income Statement > operating Income
-3953226
Quarters > 3 > income Statement > interest Expense
5622
Quarters > 3 > income Statement > pretax Income
-3618197
Quarters > 3 > income Statement > net Income
-3618197
Quarters > 3 > income Statement > eps
-0.014298460200934908
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
253048017
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-3241016
Quarters > 3 > income Statement > operating Margin
-661.7374259500738
Quarters > 3 > income Statement > total Other Income Expense Net
335028
Quarters > 3 > balance Sheet > cash
6171636
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
369677
Quarters > 3 > balance Sheet > inventories
2221823
Quarters > 3 > balance Sheet > total Current Assets
9078576
Quarters > 3 > balance Sheet > property Plant Equipment
446756
Quarters > 3 > balance Sheet > total Assets
10882632
Quarters > 3 > balance Sheet > payables
323540
Quarters > 3 > balance Sheet > short Term Debt
141845
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2584188
Quarters > 3 > balance Sheet > equity
8298444
Quarters > 3 > cash Flow > net Income
-3618197
Quarters > 3 > cash Flow > depreciation
371555
Quarters > 3 > cash Flow > change In Working Capital
277019
Quarters > 3 > cash Flow > cash From Operations
-2796286
Quarters > 3 > cash Flow > capital Expenditures
33623
Quarters > 3 > cash Flow > cash From Investing
-33621
Quarters > 3 > cash Flow > cash From Financing
-47882
Quarters > 3 > cash Flow > net Change In Cash
-2929690
Quarters > 3 > ratios > PE
-0.014298460200934908
Quarters > 3 > ratios > PB
2.439474359289525
Quarters > 3 > ratios > ROE
-43.600908796878066
Quarters > 3 > ratios > ROA
-33.24744418445832
Quarters > 3 > ratios > FCF
-2829909
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4.737034253374199
Quarters > 3 > health Score
35
Valuation > metrics > PE
-0.003238443115655531
Valuation > metrics > PB
12.237403551006448
Valuation > final Score
20
Valuation > verdict
307.9% Overvalued
Profitability > metrics > ROE
-49.537669104069224
Profitability > metrics > ROA
-39.57334084390917
Profitability > metrics > Net Margin
-8.520053880977965
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.40334646385267253
Risk > metrics > Interest Coverage
-402.6523541604975
Risk > final Score
-1551
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.959263897027995
Liquidity > metrics > Quick Ratio
3.0568976284404368
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1658
Prev Risks > 1
-3050
Prev Risks > 2
-2753
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:19.547Z
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest coil; Polarean 9820 Xenon hyperpolarizer that is designed to deliver up to 3 litres of hyperpolarized 129Xe per hour; and Polarean 2881 polarization measurement station, which provides a calibrated measurement of the polarization of hyperpolarized gas within the dose delivery inhalation bag. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APolymetal: Relisting Is A Buying Opportunity (Rating Upgrade) Seeking Alpha
Read more →Showing 2 of 3
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Polarean Imaging Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.